S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

CVE:MFS - Medifocus Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: C$0.01
52-Week Range N/A
Volume90,000 shs
Average Volume152,919 shs
Market CapitalizationC$925,000.00
P/E RatioN/A
Dividend YieldN/A
Medifocus Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus Inc. has a patent license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy for the treatment of cancers and other diseases. The company is based in Columbia, Maryland.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$2.42 million
Book ValueC($0.06) per share



Market CapC$925,000.00
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable

Receive MFS News and Ratings via Email

Sign-up to receive the latest news and ratings for MFS and its competitors with MarketBeat's FREE daily newsletter.

Medifocus (CVE:MFS) Frequently Asked Questions

What is Medifocus' stock symbol?

Medifocus trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MFS."

When is Medifocus' next earnings date?

Medifocus is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Medifocus.

Has Medifocus been receiving favorable news coverage?

Media stories about MFS stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medifocus earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Medifocus.

Who are some of Medifocus' key competitors?

What other stocks do shareholders of Medifocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus investors own include Relypsa (RLYP), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE) and Axon Enterprise (AAXN).

Who are Medifocus' key executives?

Medifocus' management team includes the folowing people:
  • Dr. William W. Jow, CEO, Pres & Director (Age 61)
  • Mr. Mirsad Jakubovic C.A., M.B.A., Chief Financial Officer (Age 57)
  • Mr. John Mon, VP of Regulatory Affairs & Product Devel. (Age 66)
  • Mr. Douglas Liu, VP of Fin. (Age 55)
  • Dr. Stuart E. Katz M.D., VP of Operations

How do I buy shares of Medifocus?

Shares of MFS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is Medifocus?

Medifocus has a market capitalization of C$0.00 and generates C$2.42 million in revenue each year. Medifocus employs 7 workers across the globe.View Additional Information About Medifocus.

What is Medifocus' official website?

The official website for Medifocus is http://www.medifocusinc.com/.

How can I contact Medifocus?

Medifocus' mailing address is The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada. The company can be reached via phone at +1-905-3197070.

MarketBeat Community Rating for Medifocus (CVE MFS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  50 (Thanks for Voting!)
Underperform Votes:  55 (Thanks for Voting!)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Medifocus and other stocks. Vote "Outperform" if you believe MFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MFS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel